EMEA Calls For NSAID Labeling Consistency, Notes “No New Safety Concerns”
This article was originally published in The Tan Sheet
Executive Summary
Labeling regarding established NSAID safety concerns should be made consistent across European Union member states, the European Medicines Agency said Oct. 17
You may also be interested in...
New EMEA NSAID Study Could Put Teeth In EU Labeling Suggestion
The European Medicines Agency is considering whether it should pursue mandatory NSAID labeling requirements across the European Union that would warn of increased risk of thrombotic events associated with use of products in the category
EMEA Will Evaluate All NSAIDs In Search Of Potential “Class Effect”
The EU health authority will undertake its own review of all non-steroidal anti-inflammatory drugs in light of safety concerns surrounding COX-2 inhibitors
Energizer Grows Personal Care With Acquisition Of Leading Sun-Care Brands
Energizer Holdings will gain Banana Boat and Hawaiian Tropic - the No. 2- and No. 4-selling sun- care brands, respectively - through its $1.9 billion purchase of Playtex Products, the companies announce July 12